The Aquilion Prime 80 features the AIDR 3D dose reduction software.
Toshiba America Medical Systems Inc. has received FDA clearance for the latest in its Aquilion CT product line, the Aquilion Prime 80 series, the company announced Monday.
The system, which features their Adaptive Iterative Dose Reduction 3D software, can generate 80 unique slices per rotation and is designed with in-field upgradeability to 160 slices, the company said.
The Aquilion Prime features a 0.5 mm detector, a 7.5 MHU large-capacity tube and 0.35 second scanning. The system also includes a 78 cm aperture gantry and a 660-pound patient-weight-capacity couch. In addition to the AIDR 3D software, the system comes with Nema XR 25 Dose Check Software which includes dose alert and notification features.
Comparative AI Study Shows Merits of RapidAI LVO Software in Stroke Detection
February 6th 2025The Rapid LVO AI software detected 33 percent more cases of large vessel occlusion (LVO) on computed tomography angiography (CTA) than Viz LVO AI software, according to a new comparative study presented at the International Stroke Conference (ISC).
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
What Emerging CT Research Reveals About Obesity and Post-Op Survival for Non-Small Cell Lung Cancer
January 29th 2025For those without low skeletal muscle mass on CT and myosteatosis, obese patients have a 23 percent lower risk of death than non-obese patients after undergoing curative resection for non-small cell lung cancer, according to newly published research.